135 related articles for article (PubMed ID: 36428284)
1. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer.
Shen C; Li N; Zhou S; Stahl K; Dodge D; Zhao H
Cancer Med; 2023 Mar; 12(6):6935-6944. PubMed ID: 36428284
[TBL] [Abstract][Full Text] [Related]
2. Radiation Without Endocrine Therapy in Older Women With Stage I Estrogen-Receptor-Positive Breast Cancer is Not Associated With a Higher Risk of Second Breast Cancer Events.
Gerber NK; Shao H; Chadha M; Deb P; Gold HT
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):40-51. PubMed ID: 33974886
[TBL] [Abstract][Full Text] [Related]
3. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
4. Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer.
Wei M; Wang X; Zimmerman DN; Burt LM; Haaland B; Henry NL
Breast Cancer Res Treat; 2021 May; 187(1):287-294. PubMed ID: 33420863
[TBL] [Abstract][Full Text] [Related]
5. Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study.
Goyal RK; Chen H; Abughosh SM; Holmes HM; Candrilli SD; Johnson ML
Cancer; 2023 Apr; 129(7):1051-1063. PubMed ID: 36760031
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women.
Nayyar A; Strassle PD; Iles K; Jameison D; Jadi J; McGuire KP; Gallagher KK
Ann Surg Oncol; 2020 Nov; 27(12):4853-4860. PubMed ID: 32918178
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis.
Tamirisa N; Lin H; Shen Y; Shaitelman SF; Karuturi MS; Giordano SH; Babiera GV; Bedrosian I
Cancer; 2021 Jul; 127(13):2196-2203. PubMed ID: 33735487
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy.
Nguy S; Wu SP; Oh C; Gerber NK
Breast Cancer Res Treat; 2021 Jun; 187(3):815-830. PubMed ID: 33590386
[TBL] [Abstract][Full Text] [Related]
9. Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
Herskovic AC; Wu X; Christos PJ; Nagar H
Clin Breast Cancer; 2018 Oct; 18(5):418-431. PubMed ID: 29530585
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
[TBL] [Abstract][Full Text] [Related]
11. Association between adjuvant radiation treatment and breast cancer-specific mortality among older women with comorbidity burden: A comparative effectiveness analysis of SEER-MHOS.
Lee E; Hines RB; Zhu J; Rovito MJ; Dharmarajan KV; Mazumdar M
Cancer Med; 2023 Sep; 12(18):18729-18744. PubMed ID: 37706222
[TBL] [Abstract][Full Text] [Related]
12. Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
Minami CA; Jin G; Freedman RA; Schonberg MA; King TA; Mittendorf EA
Ann Surg Oncol; 2024 Feb; 31(2):920-930. PubMed ID: 37851196
[TBL] [Abstract][Full Text] [Related]
13. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.
Buszek SM; Lin HY; Bedrosian I; Tamirisa N; Babiera GV; Shen Y; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):795-802. PubMed ID: 31377160
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
Daugherty EC; Daugherty MR; Bogart JA; Shapiro A
Clin Breast Cancer; 2016 Dec; 16(6):500-506.e2. PubMed ID: 27431462
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab.
Vaz-Luis I; Lin NU; Keating NL; Barry WT; Lii J; Burstein HJ; Winer EP; Freedman RA
Breast Cancer Res Treat; 2016 Aug; 159(1):151-62. PubMed ID: 27484879
[TBL] [Abstract][Full Text] [Related]
16. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
Farias AJ; Du XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
[No Abstract] [Full Text] [Related]
17. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
[TBL] [Abstract][Full Text] [Related]
18. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
[TBL] [Abstract][Full Text] [Related]
19. Adoption and effectiveness of de-escalated radiation and endocrine therapy strategies for older women with low-risk breast cancer.
Reeder-Hayes KE; Wheeler SB; Meyer AM; Baggett CD; Zhou X; Meng K; Rotter J; Zagar T
J Geriatr Oncol; 2021 Jun; 12(5):731-740. PubMed ID: 33551323
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
Adachi Y; Oze I; Sawaki M; Hattori M; Yoshimura A; Kotani H; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Nozawa K; Takatsuka D; Iwata H
Breast Cancer; 2021 Sep; 28(5):1087-1095. PubMed ID: 33886077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]